CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -28.6% | 16,600 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 16,600 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | +25.0% | 16,600 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -90.0% | 16,600 | -55.7% | 0.00% | – |
| Q1 2019 | $40,000 | -39.4% | 37,458 | -1.8% | 0.00% | – |
| Q4 2018 | $66,000 | -70.8% | 38,152 | -2.0% | 0.00% | – |
| Q3 2018 | $226,000 | +40.4% | 38,934 | +4.0% | 0.00% | – |
| Q2 2018 | $161,000 | -93.3% | 37,444 | -90.9% | 0.00% | – |
| Q1 2018 | $2,420,000 | +30.0% | 411,838 | +2.3% | 0.00% | – |
| Q4 2017 | $1,861,000 | -8.9% | 402,414 | +8.1% | 0.00% | – |
| Q3 2017 | $2,042,000 | -2.4% | 372,111 | +2.6% | 0.00% | – |
| Q2 2017 | $2,092,000 | +460.9% | 362,811 | +690.3% | 0.00% | – |
| Q1 2014 | $373,000 | +30.4% | 45,906 | +3.6% | 0.00% | – |
| Q4 2013 | $286,000 | -24.9% | 44,293 | +16.9% | 0.00% | – |
| Q3 2013 | $381,000 | – | 37,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,282,000 | 2.96% |
| COURAGE CAPITAL MANAGEMENT LLC | 100,000 | $527,000 | 0.33% |
| Crawford Lake Capital Management, LLC | 69,100 | $364,000 | 0.26% |
| Hall Kathryn A. | 31,355 | $166,000 | 0.20% |
| ELLINGTON MANAGEMENT GROUP LLC | 29,300 | $154,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $116,000 | 0.02% |
| Virtu KCG Holdings LLC | 150,357 | $792,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 2,000 | $11,000 | 0.02% |
| Jasper Ridge Partners, L.P. | 47,481 | $250,000 | 0.02% |
| AXA S.A. | 479,686 | $2,528,000 | 0.01% |